On March 16, Norges Bank purchased an additional 557,500 shares of Pharmaron (03759) at a price of HK$19.5974 per share, involving a total amount of approximately HK$10.93 million. Following this acquisition, the bank's total shareholding in the company has reached about 24.94 million shares, representing a 7.07% stake.